During the past decade, Tinto Halidou conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tinto Halidou" #1 collaborator was "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tinto Halidou" are "Malaria" (1 trials) and "Uncomplicated P. Falciparum Malaria in Children" (1 trials). Many other conditions were trialed in "Tinto Halidou" in a lesser frequency.

Most popular intervention types in "Tinto Halidou" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Artemether-lumefantrine" (2 trials) and "Artesunate-amodiaquine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tinto Halidou" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tinto Halidou". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tinto Halidou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tinto Halidou, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".